ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Effect of preoperative cancer cachexia on postoperative sarcopenia in patients with non-small cell lung cancer.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMany patients with lung cancer have cancer cachexia, which may result in complications and affect prognosis; however, its preoperative prevalence is unknown. Skeletal muscle mass loss after lung cancer surgery also affects prognosis. Although cachexia and sarcopenia share some similarities, whether preoperative cachexia affects postoperative sarcopenia is still unknown. Thus, we designed a cohort study of patients with non-small cell lung cancer (NSCLC) to investigate this. RESEARCH METHODS AND PROCEDURES: Patients with NSCLC who underwent surgery and perioperative rehabilitation were included in this study. The prevalence of preoperative cachexia and the association between preoperative cachexia and sarcopenia 1 month after surgery were tested using propensity-score matching. After matching, the regression analysis was performed to investigate whether preoperative cachexia was independently related to sarcopenia 1 month postoperatively.
resultsIn total, 126 patients (73 men) median age 71 (interquartile range 67, 76) years were included in the study. Preoperative cachexia was present in 16 (12.7%) patients, and postoperative sarcopenia was present in 29 (23%) patients. Among the 126 patients, 16 and 32 patients were included in the preoperative cachexia and control groups, respectively, as a result of matching (standardized mean difference < 0.1). After matching, regression analysis showed that preoperative cachexia was independently associated with sarcopenia at 1 month postoperatively (odds ratio 4.33, p = 0.020).
conclusionsAmong the patients with NSCLC, 12.7% had preoperative cachexia. Preoperative cachexia in patients with NSCLC affected sarcopenia 1 month postoperatively.
Indexed as
Identifiers
41203878What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.